Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giulia.arrivi@uniroma1.it
Giulia Arrivi
Dottorando
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
giulia.arrivi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
P-195 Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study
ANNALS OF ONCOLOGY
2023
Necrolytic Migratory Erythema Impact on Prognosis and Diagnosis of Glucagonoma: A Case Report
HSOA JOURNAL OF CLINICAL STUDIES & MEDICAL CASE REPORTS
2023
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study
CANCER MANAGEMENT AND RESEARCH
2022
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach
RADIOLOGY AND ONCOLOGY
2022
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis
JOURNAL OF NEUROENDOCRINOLOGY
2022
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors
CURRENT CANCER DRUG TARGETS
2022
398P Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment
ANNALS OF ONCOLOGY
2022
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis
CANCER MANAGEMENT AND RESEARCH
2022
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients: The new drug-pin® system comprehensive approach
PHARMACEUTICALS
2021
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2020
Evaluation of prognostic factors for survival in transverse colon cancer
CANCERS
2020
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC).
ANNALS OF ONCOLOGY
2020
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study
INTEGRATIVE CANCER THERAPIES
2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
CASE REPORTS IN ONCOLOGICAL MEDICINE
2019
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center
JOURNAL OF CLINICAL MEDICINE
2019
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study
2019
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours
2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
CASE REPORTS IN ONCOLOGICAL MEDICINE
2019
Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients.
RADIOTHERAPY AND ONCOLOGY
2018
« prima
< precedente
1
2
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma